Purchase Order 75N92024P00310
Award Date 9/1/24
Potential Completion Date 11/30/24
Potential Value $35K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
Total Small Business
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Wellesley Hills, Wellesley, MA 02481, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute of Dental and Craniofacial Research awarded a $21,000 firm fixed price purchase order to an unnamed prime contractor for scientific research services focused on optimizing protocols for use with the 10X Genomics Multiome platform using human salivary glands. The project has a completion date of August 14, 2024 and was awarded on January 15, 2024. No set-aside designation was used for this contract. The...
- This is a $11,242.78 firm fixed-price purchase order awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency under the Department of Health and Human Services (HHS). The contract is for the supply of chemicals required for experiments to support the agency's research programs, covering the end of the current fiscal year and start of the new fiscal year. The prime contractor is Sigma-Aldrich, Inc., a foreign-owned, for-profit organization that is...
- <p>The U.S. Federal Agency, Office of Logistics and Acquisition Operations, awarded a Firm Fixed Price Purchase Order contract to 3Xper Innoventure LTD, a foreign-owned for-profit manufacturing organization, to MANUFACTURE THE SMALL MOLECULES TO INCREASE THE TRANSLATIONAL POTENTIAL. The contract has a ceiling value of $24,200.00 and a performance period ending on December 8, 2025. The contract was awarded on December 9, 2024 and does not have a set-aside designation.</p>
- This is a $90,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), which is a civilian agency of the U.S. government. The contract, which does not have a set-aside designation, is for the "SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)" program and was awarded to DC Chemicals LIMITED, a for-profit limited liability company, on July 9, 2015. The period of performance for this contract ends on November 30, 2015.
- <p>This is a $12,750.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Hello Bio Inc., a foreign-owned for-profit organization. The contract is to provide 4-hydroxytamoxifen, a compound, in support of NIDA's ongoing intramural research experiments to understand how drug memories are stored in the brain. The contract has an ultimate completion date of October 10, 2025 and does not utilize a set-aside designation.</p>
- This is a firm fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $27,400.00, is for lab testing services and was set aside for a small business, Enamine US Inc. Based in New Jersey, Enamine US Inc. is a for-profit organization that specializes in chemical research and pharmaceutical services, and has a history of delivering...
- This is a $249,167.58 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH), to Gempharmatech LLC, a foreign-owned for-profit biotech company. The contract is for the development of humanized mouse models for nicotinamide N-methyltransferase (NNMT) and sulfotransferase (SULT1A1) using CRISPR knock-in technology. The contractor will conduct biochemical testing of inhibitors and...
- This is a $21,296 firm fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), part of the U.S. Department of Health and Human Services (HHS), to Enamine US Inc. for a set of compounds/molecules. The contract has no set-aside designation. Enamine US Inc. is a for-profit organization that provides chemical compounds and research services to support pharmaceutical, biotechnology, and other life science companies and research organizations....
- This is a $20,000.00 firm fixed-price purchase order contract awarded by the National Institute of Mental Health (NIMH), a civilian agency, to Alamar Biosciences, Inc., a for-profit manufacturer of goods. The contract has a performance period ending on June 23, 2026 and was awarded on June 24, 2025. The contract does not have a set-aside designation, indicating Alamar Biosciences successfully competed for this open market procurement. The award is focused on providing specialized research...
- This $15,735 firm fixed-price purchase order was awarded by the National Institute of Dental and Craniofacial Research (NIDCR), a component of the National Institutes of Health (NIH), to MedChemExpress LLC, a New Jersey-based provider of chemical compounds and research materials. The contract is for chemical synthesis services to produce one chemical probe compound for delivery to NIDCR. No set-aside designation was used. MedChemExpress has previously served as both a prime contractor and...
This is a $35,000.00 firm-fixed price purchase order contract awarded by the National Institute of Dental and Craniofacial Research (NIDCR), a civilian agency within the U.S. Department of Health and Human Services, to Targetmol Chemicals Inc., a foreign-owned for-profit small business. The contract is for virtual screening to identify compounds that increase the stability of the GALNT3 protein mutation. This work aligns with NIDCR's research to understand and develop treatments for genetic disorders affecting oral and craniofacial health. The contract was set aside for small business concerns and was awarded on September 1, 2024 with a completion date of November 30, 2024.
Generated 8/31/24, 10:23 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Virtual Screening | 75N92024Q1061 | Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute | Solicitation 1/1 | 8/22/24, 3:40 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.0k | 8/30/24 |